We wouldn't blame New Ray Medicine International Holding Limited (HKG:6108) shareholders if they were a little worried about the fact that Shenglei Qian, a company insider, recently netted about HK$4.1m selling shares at an average price of HK$0.10. That's a big disposal, and it decreased their holding size by 20%, which is notable but not too bad.

Check out our latest analysis for New Ray Medicine International Holding

The Last 12 Months Of Insider Transactions At New Ray Medicine International Holding

In the last twelve months, the biggest single sale by an insider was when the insider, Wen Xiaodong, sold HK$199m worth of shares at a price of HK$0.61 per share. While we don't usually like to see insider selling, it's more concerning if the sales take place at a lower price. It's of some comfort that this sale was conducted at a price well above the current share price, which is HK$0.097. So it may not tell us anything about how insiders feel about the current share price. Notably Wen Xiaodong was also the biggest buyer, having purchased HK$438m worth of shares.

Wen Xiaodong bought 609.87m shares over the last 12 months at an average price of HK$0.72. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of growing companies that insiders are buying.

Insider Ownership

I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. New Ray Medicine International Holding insiders own about HK$41m worth of shares. That equates to 25% of the company. We've certainly seen higher levels of insider ownership elsewhere, but these holdings are enough to suggest alignment between insiders and the other shareholders.

What Might The Insider Transactions At New Ray Medicine International Holding Tell Us?

An insider sold New Ray Medicine International Holding shares recently, but they didn't buy any. But we take heart from prior transactions. We like that insiders own a fair amount of the company. So we're not overly bothered by recent selling. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing New Ray Medicine International Holding. To assist with this, we've discovered 3 warning signs that you should run your eye over to get a better picture of New Ray Medicine International Holding.

Of course New Ray Medicine International Holding may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.